ARCHIVES

Book By Clinical Researcher Makes Case For Nationwide Reforms

This article is from The Cancer Letter archive.

Vol. 19 No. 31 | July 30, 1993

Download PDF Visit The Full Archive

Related Articles

In Brief: Doug Ulman named CEO of Pelotonia

September 26, 2014

Tim Lee Carter Named Chairman Of NCAB; Five Others Appointed

June 11, 1982

Novartis Submits Gleevec Data To FDA Seeking Approval For Use In GI Tumors.

October 26, 2001

ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma.

December 10, 2004

Study Links Breast, Pancreatic Cancer Risks to Lynch Syndrome

February 24, 2012

Block, Committee Agree; No New PDQ For General Public

January 11, 1985